[HTML][HTML] Serum neuroinflammatory disease-induced central nervous system proteins predict clinical onset of experimental autoimmune encephalomyelitis

I Raphael, J Webb, F Gomez-Rivera… - Frontiers in …, 2017 - frontiersin.org
There is an urgent need in multiple sclerosis (MS) patients to develop biomarkers and
laboratory tests to improve early diagnosis, predict clinical relapses, and optimize treatment …

Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis.

I Raphael, J Webb, F Gomez-Rivera, CH CA… - Frontiers in …, 2017 - europepmc.org
There is an urgent need in multiple sclerosis (MS) patients to develop biomarkers and
laboratory tests to improve early diagnosis, predict clinical relapses, and optimize treatment …

[HTML][HTML] Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis

I Raphael, J Webb, F Gomez-Rivera… - Frontiers in …, 2017 - ncbi.nlm.nih.gov
There is an urgent need in multiple sclerosis (MS) patients to develop biomarkers and
laboratory tests to improve early diagnosis, predict clinical relapses, and optimize treatment …

[PDF][PDF] serum neuroinflammatory Disease-induced central nervous system Proteins Predict clinical Onset of experimental autoimmune encephalomyelitis

I Raphael, J Webb, F Gomez-Rivera… - Frontiers in …, 2017 - researchgate.net
There is an urgent need in multiple sclerosis (MS) patients to develop biomarkers and
laboratory tests to improve early diagnosis, predict clinical relapses, and optimize treatment …

Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis

I Raphael, J Webb, F Gomez-Rivera… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
There is an urgent need in multiple sclerosis (MS) patients to develop biomarkers and
laboratory tests to improve early diagnosis, predict clinical relapses, and optimize treatment …

Serum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis.

I Raphael, J Webb, F Gomez-Rivera, CH CA… - Frontiers in …, 2017 - europepmc.org
There is an urgent need in multiple sclerosis (MS) patients to develop biomarkers and
laboratory tests to improve early diagnosis, predict clinical relapses, and optimize treatment …